White House Slams Medtronic, Inc.-Style Corporate Inversions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

President Barack Obama took time in this weeks’ regular address to criticize the wave of “corporate inversions,” in which companies, such as Medtronic (NYSE:MDT), are using outside-U.S. acquisitions to shift their headquarters overseas.

Inversions, a perfectly legal maneuver, allow companies to adopt an acquired target’s overseas base as the new headquarters, thus landing the buyer in a more favorable tax environment, especially for taxes earned overseas. A spate of companies have announced inversions in recent months, sparking a flurry of condemners and defenders.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC